Effect of treatment with different antibilharzial drugs on renal functions in urinary schistosomiasis.
D000293:Adolescent; D000328:Adult; D000965:Antimony; D002648:Child; D003404:Creatinine / Q000097:blood; D004534:Egypt; D006801:Humans; D007671:Kidney Concentrating Ability; D007677:Kidney Function Tests; D007678:Kidney Glomerulus / Q000503:physiopathology; D007684:Kidney Tubules / Q000503:physiopathology; D008297:Male; D009560:Niridazole / Q000627:therapeutic use; D011188:Potassium; D012548:Schistosoma haematobium; D012552:Schistosomiasis / Q000188:drug therapy*; D012556:Schistosomicides / Q000627:therapeutic use*; D012964:Sodium; D013386:Succinates / Q000627:therapeutic use; D013644:Tartrates / Q000627:therapeutic use; D014508:Urea / Q000097:blood; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000469:parasitology / Q000503:physiopathology; D014556:Urine / Q000382:microbiology
D012556:Schistosomicides; D013386:Succinates; D013644:Tartrates; D014508:Urea; D000965:Antimony; D012964:Sodium; D003404:Creatinine; D009560:Niridazole; D011188:Potassium